Distributed Bio cofounder Jacob Glanville’s new venture, Centivax, just raised a seed round to lay a foundation for human trials of its promising vaccine platform.
Distributed Bio cofounder Jacob Glanville’s new venture, Centivax, just raised a seed round to lay a foundation for human trials of its promising vaccine platform.